Home/Filings/4/0000899243-16-024357
4//SEC Filing

Coherus BioSciences, Inc. 4

Accession 0000899243-16-024357

$CHRSCIK 0001512762operating

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:58 PM ET

Size

6.3 KB

Accession

0000899243-16-024357

Insider Transaction Report

Form 4
Period: 2016-07-01
Herman Alan C.
Chief Scientific Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2016-07-01$16.89/sh4,250$71,775198,115 total
Holdings
  • Common Stock, $0.0001 par value

    (indirect: By Trust)
    300,164
Footnotes (3)
  • [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $16.52 to $17.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  • [F3]These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co-trustee.

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001512762

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:58 PM ET
Size
6.3 KB